A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas
(Q34750537)
scientific article
scientific article
Language:
Current Data About
A phase 2 consortium (P2C) trial of 3-aminopyridine-2-carboxaldehyde thiosemicarbazone (3-AP) for advanced adenocarcinoma of the pancreas
other details
| description | scientific article |
External Links
| (P356) |
10.1007/S10637-008-9123-6
|
| (P698) |
18278438
|
| (P932) |
4461052
|
| (P6179) |
1044292879
|